Dental Drugs

Top Drug Distributors In Talks To Settle Opioid Litigation For $18 Billion, Report Says

by CNBC

State and local officials are reportedly in talks with three major drug distributors on a potential $18 billion settlement of litigation that blames them for helping to fuel the U.S. opioid epidemic. The potential settlement, according to The Wall Street Journal, would require McKesson, AmerisourceBergen and Cardinal Health to collectively pay the $18 billion over 18 years. Drugmaker Johnson & Johnson … Read more

New Policy in Effect for Opioid Control in Dentistry

by American Dental Association

The American Dental Association (ADA) today announced a new policy on opioids supporting mandates on prescription limits and continuing education in what could be the first of its kind among major healthcare professional organizations. The policy states: The ADA supports mandatory continuing education in prescribing opioids and other controlled substances. The ADA supports statutory limits … Read more

New Protein Drug Could Fight Oral Diseases Including Caries

by Katherine Unger Baillie, Phys.org

Protein drugs, which derive from biological sources, represent some of the most important and effective biopharmaceuticals on the market. Some, like insulin, have been used for decades, while many more based on cloned genes are coming to market and are valued for their precise and powerful functions. Yet the field of dental medicine has very … Read more